Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X:
“Recent ph3 trials in the BCG naive, high-risk, NMIBC (non-muscle invasive)
BCG + IO trials: POTOMAC, CREST and ALBAN and their comparisons.”
More posts featuring N. Agarwal on OncoDaily.
